FI875272A - Baerarloesningsmedelssystem i tvao fas. - Google Patents

Baerarloesningsmedelssystem i tvao fas. Download PDF

Info

Publication number
FI875272A
FI875272A FI875272A FI875272A FI875272A FI 875272 A FI875272 A FI 875272A FI 875272 A FI875272 A FI 875272A FI 875272 A FI875272 A FI 875272A FI 875272 A FI875272 A FI 875272A
Authority
FI
Finland
Prior art keywords
baerarloesningsmedelssystem
tvao
fas
solvent
active compound
Prior art date
Application number
FI875272A
Other languages
English (en)
Other versions
FI90012C (fi
FI90012B (fi
FI875272A0 (fi
Inventor
Marcek Efraim Nimni
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of FI875272A0 publication Critical patent/FI875272A0/fi
Publication of FI875272A publication Critical patent/FI875272A/fi
Application granted granted Critical
Publication of FI90012B publication Critical patent/FI90012B/fi
Publication of FI90012C publication Critical patent/FI90012C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Gyroscopes (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Optical Communication System (AREA)
FI875272A 1986-03-31 1987-11-30 Baerarloesningsmedelssystem i tvao faser och foerfarande foer framstaellning av en farmaceutisk komposition innehaollande detta FI90012C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/846,171 US4820724A (en) 1986-03-31 1986-03-31 Dual phase solvent carrier system
US84617186 1986-03-31
PCT/US1987/000734 WO1987005806A1 (en) 1986-03-31 1987-03-31 Dual phase solvent carrier system
US8700734 1987-03-31

Publications (4)

Publication Number Publication Date
FI875272A0 FI875272A0 (fi) 1987-11-30
FI875272A true FI875272A (fi) 1987-11-30
FI90012B FI90012B (fi) 1993-09-15
FI90012C FI90012C (fi) 1993-12-27

Family

ID=25297141

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875272A FI90012C (fi) 1986-03-31 1987-11-30 Baerarloesningsmedelssystem i tvao faser och foerfarande foer framstaellning av en farmaceutisk komposition innehaollande detta

Country Status (14)

Country Link
US (1) US4820724A (fi)
EP (1) EP0261234B1 (fi)
JP (1) JP2868768B2 (fi)
KR (1) KR950008305B1 (fi)
AU (1) AU601423B2 (fi)
CA (1) CA1296630C (fi)
DK (1) DK175632B1 (fi)
ES (1) ES2004395A6 (fi)
FI (1) FI90012C (fi)
GB (1) GB2197788B (fi)
GR (1) GR870502B (fi)
HU (1) HU200912B (fi)
IE (1) IE59892B1 (fi)
WO (1) WO1987005806A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805814D0 (en) * 1988-03-11 1988-04-13 Seton Prod Ltd Topical preparations
US6929801B2 (en) * 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6998138B2 (en) * 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
BRPI0312007B1 (pt) * 2002-06-25 2015-04-14 Acrux Dds Pty Ltd Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
US7060303B2 (en) * 2002-12-31 2006-06-13 Avon Products, Inc. Use of purslane to treat facial wrinkles
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20100160244A1 (en) * 2004-09-02 2010-06-24 Marcel Nimni Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin
US7598291B2 (en) * 2004-09-02 2009-10-06 Marcel Nimni Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
US7351745B2 (en) 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
US7514092B2 (en) 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
US7618662B2 (en) * 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US7410658B2 (en) * 2004-12-22 2008-08-12 Avon Products, Inc. Use of Alisma orientale in cosmetics and compositions thereof
GB0506141D0 (en) 2005-03-24 2005-05-04 Transphase Ltd A topical compostion and its uses
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
PT1937276E (pt) 2005-10-12 2013-02-21 Besins Healthcare Luxembourg Gel de testosterona melhorado e método para a sua utilização
US7642062B2 (en) * 2006-12-29 2010-01-05 Avon Products Inc. Compositions and methods of their use for improving the condition and appearance of skin
NL2035417B9 (en) 2022-07-19 2024-10-09 Coty Inc Cosmetic composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
US4039664A (en) * 1975-04-11 1977-08-02 Nelson Research & Development Company Topical griseofulvin composition and method
JPS5636411A (en) * 1979-08-31 1981-04-09 Sumitomo Chem Co Ltd Liquid agent for external use
US4352808A (en) * 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
JPS57206610A (en) * 1981-06-12 1982-12-18 Lion Corp Anti-inflammatory analgesic solution for external use
JPS5815909A (ja) * 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
DE3233638A1 (de) * 1982-09-10 1984-03-15 Thilo & Co Gmbh Dr Dermatologische zubereitung
JPS59139325A (ja) * 1982-10-19 1984-08-10 Nissan Chem Ind Ltd 透明速乾性塗布剤組成物
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
FR2566661A1 (fr) * 1984-07-02 1986-01-03 Gendler El Methode pour dissoudre la griseofulvine en vue de preparer une solution de cette substance pour applications locales, qui soit chimiquement stable et douee d'activite biologique
JPS6169719A (ja) * 1984-09-13 1986-04-10 Kao Corp 外用抗真菌剤
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
ES2004395A6 (es) 1989-01-01
EP0261234A1 (en) 1988-03-30
FI90012C (fi) 1993-12-27
FI90012B (fi) 1993-09-15
HUT49814A (en) 1989-11-28
FI875272A0 (fi) 1987-11-30
IE59892B1 (en) 1994-04-20
EP0261234A4 (en) 1988-05-31
HU200912B (en) 1990-09-28
AU7239187A (en) 1987-10-20
GB2197788B (en) 1990-05-09
IE870800L (en) 1987-09-30
DK626187D0 (da) 1987-11-27
EP0261234B1 (en) 1991-05-15
WO1987005806A1 (en) 1987-10-08
KR950008305B1 (ko) 1995-07-27
CA1296630C (en) 1992-03-03
JP2868768B2 (ja) 1999-03-10
GB8727799D0 (en) 1987-12-31
DK626187A (da) 1988-01-25
AU601423B2 (en) 1990-09-13
DK175632B1 (da) 2004-12-27
GR870502B (en) 1987-06-10
US4820724A (en) 1989-04-11
GB2197788A (en) 1988-06-02
JPH01501145A (ja) 1989-04-20

Similar Documents

Publication Publication Date Title
FI875272A (fi) Baerarloesningsmedelssystem i tvao fas.
KR870005637A (ko) 약물 데포
FI872481A (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
EA200000629A1 (ru) Стабилизированные растворы терипаратида
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
EP0983995A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DK261490D0 (da) New pharmaceutical compound
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
SE8804628D0 (sv) New compounds
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
FI865347A0 (fi) Gonadoliberinderivat som innehaoller en aromatisk aminokarbozylsyra i position 6, farmaceutiska och veterinaera preparat innehaollande dessa och foerfarande foer framstaellning daerav.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
AU4040195A (en) Topical composition containing penciclovir
MY110074A (en) Pharmacuetical formulation.
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ES2032476T3 (es) Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
ATE155041T1 (de) Rectale pharmazeutische zubereitung fuer die behandlung von prostataanschwellung
KR890700028A (ko) 약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
KR910007540A (ko) 혈구 감소 장해의 예방ㆍ치료제
IT8619431A0 (it) Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono, procedimento per prepararlo e intermedio utile in detto procedimento.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: UNIVERSITY OF SOUTHERN CALIFORNIA

MA Patent expired